We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current XTCYF market cap is 2.62M. The company's latest EPS is CAD -0.0106 and P/E is -11.32.
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -2.82M | -324k | -3.27M | -521k | -11k |
Net Income | -2.37M | -1.38M | -3.58M | -1.37M | -520k |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 769k | 4k | 26k | 298k | 367k |
Total Liabilities | 159k | 264k | 543k | 747k | 703k |
Total Equity | 610k | -260k | -517k | -449k | -336k |
Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -1.36M | -61k | -98k | -426k | -81k |
Investing | N/A | 47k | N/A | N/A | N/A |
Financing | 452k | N/A | 120k | 400k | 81k |
Market Cap | 2.62M |
Price to Earnings Ratio | -11.32 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | -17.58 |
Dividend Yield | - |
Shares Outstanding | 49.21M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 64.13k |
52 Week Change | 93.08% |
52 Week High | 0.21 |
52 Week Low | 0.0068 |
Spread (Intraday) | 0.16 (95.55%) |
Company Name | XTACU Therapeutics Corporation (QB) |
Address |
1100 - 1111 melville st vancouver vancouver, british columbia V6E 3V6 |
Website | https:// |
Industry | oil & gas field services,nec (1389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions